missing translation for 'onlineSavingsMsg'
Learn More
Learn More
STEMCELL Technologies JIB-04
Description
- JIB-04 is an epigenetic modifier that is a pan-selective inhibitor of Jumonji histone demethylase enzymes
- It inhibits members of the family in the high nanomolar range with IC50 values of 230, 340, 435, 445, 855 and 1100 nM for JARID1A, JMJD2E, JMJD2B, JMJD2A, JMJD3, and JMJD2C, respectively
- It shows no activity against histone deacetylases and minimal effects against iron-containing enzymes methylcytosine dioxygenase TET1 and prolyl hydroxylases (Wang et al.; Easmon et al.)
- Inhibits proliferation in a variety of human tumor cell lines (Easmon et al.)
- Selectively toxic to lung or prostate cancer cells in vitro, and not to normal cells of the same cell type or to normal control lines isolated from the same patient (Wang et al.)
- Reduces tumor burden and prolongs survival in a mouse model of breast cancer (Wang et al.)
Specifications
Specifications
| CAS | 199596-05-9 |
| Synonym | JHDM Inhibitor VII; NSC 693627 |
| Quantity | 10 mg |
| Molecular Formula | C17H13ClN4 |
| Purity | ≥95% |
Product Title
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.
Spot an opportunity for improvement?